Letters to the Editor

Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance.

Dept. of Experimental Medical Science, Medical Structural Biology, Lund University, Sweden;
Dept. of Experimental Medical Science, Medical Structural Biology, Lund University, Sweden;
Dept. of Experimental Medical Science, Medical Structural Biology, Lund University, Sweden;
Dept. of Experimental Medical Science, Medical Structural Biology, Lund University, Sweden;
Dept. of Laboratory Medicine, Division of Clinical Genetics, Lund University, Sweden;
Department of Pharmacy, University of Pisa, Pisa, Italy
Department of Pharmacy, University of Pisa, Pisa, Italy
Department of Pharmacy, University of Pisa, Pisa, Italy
Department of Pharmacy, University of Pisa, Pisa, Italy
Dept. of Laboratory Medicine, Division of Clinical Genetics, Lund University, Sweden;
Dept. of Experimental Medical Science, Medical Structural Biology, Lund University, Sweden;
Haematologica Early view Jun 18, 2020 https://doi.org/10.3324/haematol.2020.246843